Insider · CIK 0001574589

Curnutte John T

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001574589

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+70K sh	—	—	70,000
2025-06-05	PLRXPLIANT THERAPEUTICS, INC. · Common Stock (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-13	PLRXPLIANT THERAPEUTICS, INC. · Common Stock (Right to Buy)A Award	Director	AAward	+26.8K sh	—	—	26,764
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−105K sh	—	—	0
2023-06-14	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+105K sh	—	—	105,000
2023-06-07	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,000
2022-06-16	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-06-07	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+46K sh	—	—	46,000
2021-06-29	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,286
2021-06-16	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-17	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2019-05-20	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−2,418 sh	$28.69	−$69.4K	102,559
2019-05-20	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−903 sh	$28.69	−$25.9K	101,656
2019-05-17	PORTOLA PHARMACEUTICALS INCPerformance Stock UnitM Exercise/Conversion	EVP R&D	MExercise/Conversion	−4,688 sh	—	—	0
2019-05-17	PORTOLA PHARMACEUTICALS INCA Award	EVP R&D	AAward	+4,688 sh	—	—	103,227
2019-05-17	PORTOLA PHARMACEUTICALS INCA Award	EVP R&D	AAward	+1,750 sh	—	—	104,977
2019-03-04	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−6,446 sh	$33.41	−$215K	98,539
2019-01-31	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP R&D	AAward	+18K sh	—	—	18,000
2019-01-31	PORTOLA PHARMACEUTICALS INCA Award	EVP R&D	AAward	+4,500 sh	—	—	104,985
2019-01-15	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−715 sh	$24.25	−$17.3K	100,485
2019-01-12	PORTOLA PHARMACEUTICALS INCA Award	EVP R&D	AAward	+1,750 sh	—	—	101,200
2018-09-04	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−8,884 sh	$29.18	−$259K	101,200
2018-08-31	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	EVP R&D	MExercise/Conversion	+17.5K sh	—	—	110,084
2018-08-23	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−8,171 sh	$26.05	−$213K	110,084
2018-07-28	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	EVP R&D	MExercise/Conversion	+17.5K sh	—	—	118,255
2018-05-22	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−1,647 sh	$40.82	−$67.2K	118,255
2018-05-22	PORTOLA PHARMACEUTICALS INCA Award	EVP R&D	AAward	+4,687 sh	—	—	119,902
2018-03-12	PORTOLA PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)M Exercise/Conversion	EVP R&D	MExercise/Conversion	−5,049 sh	—	—	0
2018-03-12	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	EVP R&D	MExercise/Conversion	+5,049 sh	$8.50	+$42.9K	5,049
2018-03-02	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−4,530 sh	$32.53	−$147K	22,499
2018-01-31	PORTOLA PHARMACEUTICALS INCA Award	EVP R&D	AAward	+8,750 sh	—	—	8,750
2018-01-31	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	EVP R&D	AAward	+35K sh	—	—	35,000
2017-09-28	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	EVP R&D	MExercise/Conversion	+6,715 sh	$8.50	+$57.1K	6,715
2017-09-28	PORTOLA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	EVP R&D	MExercise/Conversion	−14.3K sh	—	—	0
2017-09-28	PORTOLA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	EVP R&D	MExercise/Conversion	−6,715 sh	—	—	5,049
2017-09-28	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	EVP R&D	MExercise/Conversion	+14.3K sh	$7.00	+$100K	14,285
2017-08-16	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−2,644 sh	$54.86	−$145K	0
2017-07-18	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP R&D	MExercise/Conversion	−10K sh	—	—	1,918
2017-07-18	PORTOLA PHARMACEUTICALS INCS Sale	EVP R&D	SSale	−10K sh	$65.00	−$650K	0
2017-07-18	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	EVP R&D	MExercise/Conversion	+10K sh	$8.50	+$85K	10,000
2017-06-26	PORTOLA PHARMACEUTICALS INCS Sale	EVP R&D	SSale	−10.7K sh	$57.24	−$614K	31,756
2017-06-26	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	EVP R&D	MExercise/Conversion	+60K sh	$8.50	+$510K	60,000
2017-06-26	PORTOLA PHARMACEUTICALS INCS Sale	EVP R&D	SSale	−6,159 sh	$55.47	−$342K	53,841
2017-06-26	PORTOLA PHARMACEUTICALS INCS Sale	EVP R&D	SSale	−11.4K sh	$56.71	−$644K	42,485
2017-06-26	PORTOLA PHARMACEUTICALS INCS Sale	EVP R&D	SSale	−18K sh	$58.35	−$1.05M	13,802
2017-06-26	PORTOLA PHARMACEUTICALS INCS Sale	EVP R&D	SSale	−3,802 sh	$59.33	−$226K	10,000
2017-06-26	PORTOLA PHARMACEUTICALS INCS Sale	EVP R&D	SSale	−10K sh	$60.00	−$600K	0
2017-06-26	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	EVP R&D	MExercise/Conversion	−60K sh	—	—	11,918
2017-03-02	PORTOLA PHARMACEUTICALS INCF Tax Payment	EVP R&D	FTax Payment	−3,327 sh	$38.61	−$128K	34,152

Recent filings

Accepted (ET)
Jun 124
Curnutte John T0001746473-26-000101
SEC(opens sec.gov)
Jun 94
Curnutte John T0001746473-25-000129
SEC(opens sec.gov)
Jun 174
Curnutte John T0001746473-24-000100
SEC(opens sec.gov)
Jan 244
Curnutte John T0000950170-24-007052
SEC(opens sec.gov)
Jun 164
Curnutte John T0001209191-23-037906
SEC(opens sec.gov)
Jun 84
Curnutte John T0001209191-23-035529
SEC(opens sec.gov)
Jun 214
Curnutte John T0001567619-22-013194
SEC(opens sec.gov)
Jun 84
Curnutte John T0001209191-22-035006
SEC(opens sec.gov)
Jun 304
Curnutte John T0001209191-21-044172
SEC(opens sec.gov)
Jun 174
Curnutte John T0001209191-21-041499
SEC(opens sec.gov)
Jun 194
Curnutte John T0001209191-20-037907
SEC(opens sec.gov)
May 214
Curnutte John T0001209191-19-031875
SEC(opens sec.gov)
Mar 54
Curnutte John T0001209191-19-016927
SEC(opens sec.gov)
Feb 44
Curnutte John T0001209191-19-006902
SEC(opens sec.gov)

Companies

Address

C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080